Skip to content

Lipoatrophy common in children receiving d4T in South Africa

Lopinavir/ritonavir cuts malaria risk in children with HIV

Lopinavir/ritonavir cuts malaria risk in children with HIV

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

Four doses of PrEP a week may be enough to protect

Detail from iPrEx materials (www.globaliprex.com).

A tale of two trials: how adherence is everything in PrEP

Jared Baeten. Photo by Gus Cairns / aidsmap.com

FDA updates guidance for use of HIV and hepatitis C protease inhibitors with statins

HIV treatment isn't a risk factor for liver dysfunction, but HIV infection is

Fat accumulation linked to cognitive impairment in patients with HIV

Second-line treatment failure most often due to poor adherence in low and middle-income countries